Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vaginal physicochemical environment is a dynamic physiological system that serves as a primary innate defense against urogenital infections. It is characterized by a low pH (typically 3.8 to 4.5), a high concentration of lactic acid, and a microbiome typically dominated by Lactobacillus species (StatPearls, NBK557433). These factors work synergistically to inhibit the colonization and overgrowth of pathogenic bacteria, fungi, and viruses (PubMed, 29447491). The environment also includes the cervicovaginal mucus, which provides a physical and chemical barrier containing antimicrobial peptides and antibodies. Alterations in this environment, such as an increase in pH or a loss of Lactobacillus dominance, are central to the pathogenesis of bacterial vaginosis and vulvovaginal candidiasis (CDC, Bacterial Vaginosis). Such disruptions also increase the risk of acquiring sexually transmitted infections like HIV and HPV. Therapeutic strategies targeting this environment do not focus on a single receptor but rather aim to restore the overall physicochemical balance. This is achieved through the use of acidifying agents like boric acid, probiotics to replenish commensal flora, or estrogen therapy to maintain the health of the vaginal epithelium (PubMed, 21774671).
Restoration of vaginal pH, replenishment of commensal microbiota, and maintenance of mucosal barrier integrity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal physicochemical environment.